Investment Q&A

Q: Why the big drop in AbbVie today (Monday)? Is it a stock you would sell, hold or buy? Thank you

Q: Hello, I keep missing the boat on BKNG, I know I asked this question recently, but, it never came down to its adjusted price I was hoping for. Would you dive in at current prices or does EXPE make more sense ?

Thanks.

Q: So Elon's gamble of aligning himself with the Donald, appears to have been good for his stock. My 3% position in TSLA is now finally above even - which is the point I said I would sell and buy a tech ETF instead. But as TSLA might keep climbing, I'm now wondering if selling just my upside periodically, and keeping my position at 3%, might work - until the knife starts to fall again. In other words, is a bird in hand really worth two in the bush, and how hard is it to catch a falling knife?

Q: A while ago you guys offered up an interview with Chris and Peter. They were talking about the ideal stocks and why Peter selects them.

The recco from Peter during that episode was Axon and why it was so amazing. Well, everything Peter stated has proven to be right and stock is up close to 100%.

Does Peter have another stock he loves as much as Axon was loved during that interview?

With thanks

Sheldon

Q: Hello 5iR,
What do you think of the latest earnings? Would you buy the stock here, or are these eanings not sustainable?
Thank you. Cheers

Q: This company appears to be killing it - but at 77 PE does seem a bit rich. what is the expected growth rate (PEG) - i know- stocks hitting new highs.... :) any competitive risks out there?

Q: thoughts thanks

Q: I have been following this company for a while, with the idea of purchasing a position. Things seem to be moving forward, decent growth. Looking at Q3 results would you see this as a time to become a shareholder?
Why?

Q: ISRG has been on a tear lately. While see it as a stock you often mention for a buy/hold, I’d appreciate some insight on a reasonable entry price range (if there is one), and some background on why this stock ranks repeatedly as a buy in your assessments.

Thanks!

Dave

Q: I have a question regarding the ticker CORZ. I know you have provided information on MARA and would like your opinion on this name. I have bought some for my grandkids and am wondering with the election now decided and the new incumbent being pro crypto and the possibility of the government setting up a Bitcoin Reserve, is this a name you would be comfortable with? They just reported earnings yesterday. Thank-you!

Q: Could you give me your take on Doximity earnings please?

Q: Could you please provide update on MP Materials. What is their balance sheet? Would you buy it?

Thanks,
Milan

Q: Good afternoon,
I have a full position in ITA, would a switch to XLI which has 22% Aerospace & Defense be wise at this juncture for the added diversification while still having defense stock exposure or do you see defense outperforming?

Q: What should be a fair market price based solely on q3 numbers. What would a quick general calculation I could use for this and other similar companies using some metric like price to cash flow. Thanks for your help.

Q: For a buy today, how would you rate them?
Thanks Again

Q: Do you think post-election sentiment on solar is overly negative? At what point might solar investments start to look appealing again? Would you consider Enphase as a preferred investment option in this scenario? If not, could you recommend a solar stock with strong potential should sentiment improve.

Q: I would appreciate you explain in clear and vulgar words in what consists exactly this etf, its interaction with the nvda stock and in which circumstances it could be envisaged to buy some parts.

I thank you very much in advance

Q: Can you suggest tax loss proxy ideas for ASPN?

Q: Good Mornings,

With much thanks to 5i, my winning stocks far outweigh my losers. However, I'm thinking of doing a little post election portfolio cleanup of two stocks.

Just trying to decide if I should consider cutting my losses on Aspen Aerogels and Transmedics, or if you think the analysts might have it correct and they are worth holding for another quarter or two?

I think I may have missed the boat on Axon, which I have deliberated about buying for two years. It has gone up so rapidly with the Trump win, that it may do some consolidating for a while.

If you have some small-mid cap suggestions that you think are showing good momentum and might be a replacement for ASPN and TMDX, please give me a few ideas. This could include Axon or any other sector stock, US or Canadian.

Thanks very much,

Brad

Q: The shares of CHKP had a significant drop recently. Was there anything in the last quarterly report that spooked investors? Does the current price offer a buying opportunity?
Many thanks for your thoughts.
Ian